Rat-tissue fat synthesis
The enzyme has a long name. The action under investigation is simpler: making less new fat.
Acetyl-CoA carboxylase
In the 1983 study of adipocyte and hepatocyte preparations, human growth hormone and a fragment called hGH 172-191 inhibited acetyl-CoA carboxylase. These were preparations of fat cells and liver cells, rather than a trial in people. The enzyme participates in fatty-acid synthesis.
The researchers connected the effect to interaction with the cell membrane and release of a second messenger that increased the enzyme’s phosphorylation. That last term describes adding a phosphate group; here it was associated with inhibition of the enzyme. The result gives the proposed fat-synthesis action a biochemical address.
The precision appeals to my suspicious streak: the longer explanation asks less of its result. ‘Making less’ leaves open the questions that a sweeping fat-loss claim rushes past: in which preparation, through which reaction, and with which fragment?
The fat-pad experiment
The 1993 experiment used synthetic hGH 177-191, a different C-terminal sequence from the hGH 172-191 in the earlier enzyme work. C-terminal means the end region of the hormone’s amino-acid chain. In rat epididymal fat pads studied outside the animal, this fragment showed antilipogenic activity identical to intact growth hormone.
The same study reports no significant lipolytic effect when assessed by glycerol release. Lipolysis is the breaking down of stored fat. My useful-sounding umbrella term, ‘fat metabolism’, has become less convenient. The assay now makes me distinguish the actions.
A result in that glycerol-release assay has a precise scope. It describes those rat-tissue conditions. Later findings with other fragments, models or measurements can be considered alongside it without turning the earlier result into a universal verdict.
The hGH 177-191 mouse study
A 1994 study of synthetic hGH 177-191 in obese ob/ob mice extended the question beyond isolated tissue. Chronic treatment reduced cumulative body-weight gain and adipose-tissue mass and significantly inhibited fat synthesis in adipose tissue.
‘Reduced cumulative body-weight gain’ deserves to stay intact. I cannot replace it with ‘weight loss’ simply because the shorter phrase sounds more decisive. The animals’ weight trajectory and their fat synthesis were both relevant to this experiment, and the wording preserves the distinction.
AOD-9604 appears in later metabolic studies of a synthetic growth-hormone domain. The hGH 177-191 findings above belong to that earlier fragment. For AOD-9604 itself, the mouse-receptor experiment supplies a different puzzle.